Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib
Condition(s):Leukemia, Myeloid, ChronicLast Updated:October 30, 2013Terminated
Hide Studies Not Open or Pending
Condition(s):Leukemia, Myeloid, ChronicLast Updated:October 30, 2013Terminated
Condition(s):Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous LeukemiaLast Updated:February 22, 2024Active, not recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:November 28, 2023Completed
Condition(s):Chronic Myeloid Leukemia (CML)Last Updated:April 21, 2016Completed
Condition(s):LeukemiaLast Updated:February 4, 2013Completed
Condition(s):Chronic Myelocytic LeukemiaLast Updated:November 4, 2019Unknown status
Condition(s):Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveLast Updated:November 13, 2023Active, not recruiting
Condition(s):Leukemia; Myelogenous Leukemia; Chronic Leukemia; BCR-ABL Positive Acute Myeloid LeukemiaLast Updated:August 30, 2023Recruiting
Condition(s):Chronic Phase Chronic Myelogenous LeukemiaLast Updated:January 5, 2023Recruiting
Condition(s):Hematologic Diseases; Chronic Myeloid LeukemiaLast Updated:April 28, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.